Facebook removes misleading HIV lawsuit adsHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Facebook removes misleading HIV lawsuit adsCortney MooreFox BusinessJanuary 3, 2020ReblogShareTweetShareFacebook removed misleading advertisements regarding HIV drug plaintiffs after critics argued that providing a platform for such content endangers public health, according to a report from The Washington Post.Advocates from HIV/AIDS prevention, LGBTQ and health groups co-signed an open letter in December through the Gay and Lesbian Alliance Against Defamation’s website, which urged Facebook to pull the ads.FACEBOOK OPERATING SYSTEM IN THE WORKS, BUT CRITICS ARE SKEPTICALThe ads in question were published by various law firms seeking clients for potential personal injury lawsuits over side effects from the pre-exposure HIV prescription medication, Truvada for PrEP, developed by biotechnology company Gilead Sciences.FACEBOOK EXPANDS TODAY IN NEWS SERVICE TO 6,000 CITIESFacebook initially declined to remove the ads, however, the company finally followed through on the letter’s request after a third-party fact-checker Science Feedback agreed that the ads contained misinformation.“Some of the ads in question mislead people about the effects of Truvada,” a Facebook spokeswoman told The Washington Post. “As a result, we have rejected these ads and they can no longer run on Facebook.”In a published verdict, Science Feedback wrote that law firms were overstating the adverse side effects associated with Truvada for PrEP.FACEBOOK INTRODUCING NEW COMPANY BRANDING“The removal of select ads is a strong first step given the findings of Facebook’s own fact-checking agency and the dozens of organizations that spoke out," said Sarah Kate Ellis, the president and CEO of GLAAD. “Time is now for Facebook to take action on other very similar ads which target at-risk community members with misleading and inaccurate claims about PrEP and HIV prevention.”GET FOX BUSINESS ON THE GO BY CLICKING HERE“We join calls to have any misleading advertisements related to Gilead’s HIV medications removed from Facebook," Amy Flood, a senior vice president at Gilead said in a statement sent to FiercePharma regarding the issue.CLICK HERE TO READ MORE ON FOX BUSINESSRelated ArticlesUnder Armour Outsmarts Olympics In Phelps PromosTwitter Suspends 360,000 Accounts for Promoting TerrorismU.S. Olympic Teams' Most Sizzlin' Hotties in RioReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoFrankie Muniz Is Married! Malcolm in the Middle Star Weds Paige PricePeopleDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoViacomCBS Layoffs Underway As Re-Merged Company Continues To Cut CostsDeadlineStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceSomething 'dangerous' is happening beneath the surface of the market selloffYahoo Finance'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo Finance